Indirect bilirubin is the form of bilirubin that has not yet been processed by the liver. It forms when red blood cells break down and release heme, which gets converted into bilirubin that travels through the bloodstream bound to a protein called albumin. Because it hasn’t been made water-soluble by the liver, indirect bilirubin is sometimes called “unconjugated” bilirubin. When your blood test shows a total bilirubin level, indirect bilirubin typically makes up the majority of that number, and elevations in this fraction point to a different set of problems than elevations in the direct (conjugated) fraction.
How Indirect Bilirubin Is Made
Your body produces bilirubin continuously as part of its normal recycling process. Red blood cells live for roughly 120 days before the spleen and liver break them down. The hemoglobin inside those cells contains heme, which an enzyme called heme oxygenase splits into three things: iron (which gets reused), carbon monoxide (exhaled through the lungs), and a green pigment called biliverdin. Another enzyme quickly converts biliverdin into bilirubin, the yellow-orange compound responsible for the color of bruises as they heal and, when levels climb too high, the yellowing of jaundice.1PubMed Central. The Heme Oxygenase/Biliverdin Reductase System and Its Genetic Variants in Physiology and Diseases
At this stage the bilirubin is indirect bilirubin. It doesn’t dissolve well in water, so it hitches a ride on albumin through the blood to the liver. Inside liver cells, a transporter protein pulls it in, and an enzyme called UGT1A1 attaches sugar molecules to it, making it water-soluble. That modified version is direct (conjugated) bilirubin, which gets pumped into bile and eventually leaves the body through stool.2PubMed Central. Synthetic augmentation of bilirubin metabolism in human pluripotent stem cell-derived liver organoids When anything disrupts either the production side (too many red blood cells breaking down at once) or the processing side (the liver can’t conjugate fast enough), indirect bilirubin builds up in the blood.
Normal Levels and What the Numbers Mean
A standard blood panel reports three bilirubin values: total bilirubin, direct bilirubin, and indirect bilirubin. Indirect bilirubin is usually calculated by subtracting the direct value from the total rather than being measured on its own. In most adults, total bilirubin runs between about 0.1 and 1.2 mg/dL, with indirect bilirubin accounting for roughly 0.2 to 0.8 mg/dL of that. The exact reference ranges vary slightly between labs.
What matters clinically is not just whether indirect bilirubin is elevated but by how much and in what context. A mildly elevated level in an otherwise healthy young adult often turns out to be Gilbert syndrome, a harmless genetic quirk. A sharply elevated level alongside anemia and other markers of red blood cell destruction points toward hemolytic disease. In newborns, the thresholds are entirely different because their livers are still maturing, and levels that would be unremarkable in an adult can be dangerous in a days-old infant.
Common Causes of Elevated Indirect Bilirubin
Hemolytic Conditions
Anything that destroys red blood cells faster than usual floods the system with heme and, consequently, with indirect bilirubin. Immune-mediated hemolysis occurs when the body’s own antibodies attack red blood cells, as happens in autoimmune hemolytic anemia or in blood-type mismatches between a mother and her newborn. Non-immune causes include inherited red blood cell defects like sickle cell disease, thalassemia, and hereditary spherocytosis, as well as infections such as malaria that directly damage red blood cells.3PubMed Central. Clinical Applications of Hemolytic Markers in the Differential Diagnosis and Management of Hemolytic Anemia In neonates, hemolytic causes are significant and sometimes underrecognized contributors to dangerously high bilirubin.4PubMed Central. Neonatal Hemolytic Jaundice: Causes, Diagnostic Approach, and Management
Gilbert Syndrome
Gilbert syndrome is the single most common reason a healthy adult walks into a clinic with mildly elevated indirect bilirubin. It affects somewhere around 5 to 10 percent of the population, depending on how the studies define it. The cause is a genetic variation in the UGT1A1 gene that reduces the liver’s ability to conjugate bilirubin by about 70 percent. People with Gilbert syndrome tend to notice a slight yellowing of the eyes during periods of fasting, illness, or heavy exercise, then it fades on its own.5PubMed Central. Evaluating Elevated Bilirubin Levels in Asymptomatic Adults It requires no treatment and doesn’t damage the liver. The main practical consequence is that it can cause unnecessary worry when bilirubin shows up high on a routine blood panel.
Crigler-Najjar Syndrome
Where Gilbert syndrome represents a mild reduction in UGT1A1 activity, Crigler-Najjar syndrome sits at the severe end of the spectrum. It is a rare genetic disorder caused by mutations in the same gene. Type 1, the more severe form, involves a complete absence of the enzyme, leading to dangerously high unconjugated bilirubin from birth. Type 2 retains partial enzyme activity and tends to be more manageable.6PubMed Central. Therapeutic Options for Crigler-Najjar Syndrome: A Scoping Review Type 1 often requires daily phototherapy sessions throughout life, and liver transplant remains the only definitive cure. Distinguishing between UGT1A1-related causes and hemolytic causes of chronically elevated indirect bilirubin can be a clinical challenge because the two overlap in presentation.7World Journal of Hepatology. Novel nomogram for differential diagnosis of UGT1A1 gene mutation-associated unconjugated hyperbilirubinemia with hemolytic diseases
Medications
Certain drugs can push indirect bilirubin up either by causing red blood cell destruction or by interfering with the liver’s conjugation machinery. Rifampicin, commonly used to treat tuberculosis, can cause a transient spike in indirect bilirubin early in treatment before levels normalize later on.8PubMed Central. Biphasic Effect of Rifampicin on Bilirubin- A Case Report Other medications known to interfere include some antibiotics and antivirals. In people who already have reduced conjugation capacity, like those with Gilbert syndrome, the effect of these drugs can be more pronounced.
How Doctors Test for It
The basic test is a standard blood draw measuring total and direct bilirubin, with the indirect fraction calculated by subtraction. But when indirect bilirubin comes back elevated, figuring out why usually requires additional tests. The workup depends on the clinical picture, but a few markers come up repeatedly.
If hemolysis is suspected, doctors look at a cluster of markers together rather than relying on any single value. Elevated lactate dehydrogenase (LDH) is a sign that cells are being destroyed. Haptoglobin, a protein that binds free hemoglobin, drops when there’s ongoing hemolysis because it gets used up. A reticulocyte count tells you whether the bone marrow is ramping up red blood cell production to compensate for losses. A peripheral blood smear lets a lab technician see whether the red blood cells look abnormal under a microscope, which helps narrow down specific inherited conditions. Routine markers like LDH, indirect bilirubin, and haptoglobin correlate well with the degree of hemolysis and serve as practical, cost-effective tools even in settings with limited access to specialized testing.9International Journal of Current Pharmaceutical Review and Research. Correlation of Serum Lactate Dehydrogenase, Indirect Bilirubin, and Haptoglobin with Hematological Parameters in Hemolytic Anemia: A Cross-Sectional Study from a Tertiary Care Center in Rajasthan The direct antiglobulin test (Coombs test) is the cornerstone for identifying autoimmune forms of hemolysis.3PubMed Central. Clinical Applications of Hemolytic Markers in the Differential Diagnosis and Management of Hemolytic Anemia
If hemolysis has been ruled out and the elevation is persistent, genetic testing for UGT1A1 mutations can confirm Gilbert or Crigler-Najjar syndrome. In practice, Gilbert syndrome is often diagnosed clinically: a young adult with mildly elevated indirect bilirubin, no signs of liver disease, and no hemolysis usually gets the label without needing genetic confirmation.
Indirect Bilirubin in Newborns
Neonatal jaundice is one of the most common reasons newborns need medical attention, and indirect bilirubin is almost always the culprit. The imbalance is straightforward: newborns produce bilirubin at roughly two to three times the adult rate (because their fetal red blood cells have a shorter lifespan and break down quickly after birth), while their immature livers conjugate it slowly.10Neoreviews. Neonatal Indirect Hyperbilirubinemia Most of the time, this “physiologic” jaundice peaks around day three to five and resolves on its own.
Breastfeeding adds a layer of complexity. Two distinct patterns exist, though they’re frequently confused. Early-onset breastfeeding jaundice typically shows up in the first week and results from inadequate feeding: the baby isn’t getting enough milk, stool output is low, and bilirubin that would normally leave through the gut gets reabsorbed. Late-onset breast milk jaundice is a separate phenomenon that can persist for weeks, likely driven by substances in the milk itself that slow bilirubin conjugation or increase intestinal reabsorption.11PubMed. Breastfeeding and breast milk jaundice In breastfeeding jaundice, bilirubin usually peaks within the first five or six days, and the fix is improving feeding frequency and technique. Phototherapy is considered when levels exceed roughly 18 to 20 mg/dL.12International Journal Of Community Medicine And Public Health. Difference between breast milk jaundice and breast-feeding jaundice: literature review
When Levels Become Dangerous
The reason high indirect bilirubin gets taken seriously, especially in newborns, is that unconjugated bilirubin can cross the blood-brain barrier. In adults, albumin keeps most of it bound and out of the brain. But in newborns with very high levels, or in anyone with conditions that reduce albumin binding (prematurity, certain drugs, sepsis), free bilirubin can enter brain tissue and cause damage.
The initial stage, called acute bilirubin encephalopathy, involves lethargy, poor feeding, and abnormal muscle tone. High levels of free bilirubin in the brain trigger inflammation: microglial cells activate and release inflammatory molecules, which compounds the injury.13Research and Reports in Neonatology. Acute bilirubin encephalopathy and its progression to kernicterus: current perspectives At the cellular level, unconjugated bilirubin disrupts membranes, collapses the energy-producing machinery of mitochondria, and drives up intracellular calcium to toxic levels, ultimately triggering cell death.14PubMed Central. The Role of ER Stress in Bilirubin Neurotoxicity: A Complex Molecular Network If untreated, this progresses to kernicterus, a form of permanent brain damage characterized by movement disorders, hearing loss, and intellectual disability. Conditions involving systemic inflammation, like sepsis, make the brain more vulnerable to bilirubin injury even at levels that might otherwise be tolerable.
Phototherapy and How It Works
The primary treatment for dangerously high indirect bilirubin in newborns is phototherapy: placing the baby under specific wavelengths of blue-green light. The light doesn’t destroy bilirubin. Instead, it transforms the molecule’s shape, creating photoisomers that are more water-soluble than the original compound.15PubMed Central. Bilirubin Photoisomers in Neonatal Jaundice The most important of these photoproducts is lumirubin, a structural rearrangement of bilirubin that the body can excrete through bile and urine without needing the liver’s conjugation step at all. Studies have found lumirubin to be the principal bilirubin photoproduct in the bile of infants during phototherapy, with a serum half-life of roughly 80 to 160 minutes.16PubMed Central. Rapid clearance of a structural isomer of bilirubin during phototherapy
For adults with Crigler-Najjar syndrome type 1, phototherapy remains a lifelong necessity. These patients often spend 10 to 12 hours a day under lights. As the body grows and the skin-to-body-mass ratio shrinks, the therapy becomes less effective over time, which is why liver transplant is often pursued.
The Skin Tone Problem in Screening
In nurseries, a handheld device called a transcutaneous bilirubinometer (TcB meter) is often used to estimate bilirubin levels without drawing blood, by shining light through the skin and measuring the reflected color. It’s convenient and non-invasive, but it has a well-documented limitation: accuracy depends on skin pigmentation.
Systematic testing has shown that darker skin tones cause the devices to overestimate bilirubin, and the error grows larger as both skin color and actual bilirubin level increase. At lower bilirubin levels, the readings stay within acceptable accuracy for all skin tones. But above certain thresholds, the discrepancy in darker-skinned infants can exceed clinical safety margins by a wide margin.17Pediatric Research. Skin color influences transcutaneous bilirubin measurements: a systematic in vitro evaluation One study found that 90 percent of darker-skinned neonates had TcB overreads, while light-skinned neonates were more likely to have falsely low readings.18Clinical Chemistry. Evaluating Discrepancies in Transcutaneous Bilirubin Measurements: The Impact of Skin Tone and Device Precision on Neonatal Jaundice Screening
The practical consequence is that TcB readings in darker-skinned babies may trigger unnecessary blood draws (since the reading looks higher than reality), while in lighter-skinned babies, a falsely low reading could delay needed intervention. Most clinical protocols already treat TcB as a screening tool rather than a definitive measurement, requiring a confirmatory blood test (total serum bilirubin) before starting phototherapy. But the size of the error in darker skin tones, up to 130 µmol/L off in extreme cases, underscores why that confirmatory step is non-negotiable.
Fasting and Diet Effects
If you have Gilbert syndrome and have noticed that skipping meals makes your eyes look yellowish, you’re not imagining it. Caloric restriction causes a disproportionate rise in indirect bilirubin in people with reduced UGT1A1 function compared to people with normal enzyme levels. Research has shown that this diet-induced spike is driven by the underlying enzyme deficiency rather than by the baseline bilirubin level itself.19PubMed. Caloric intake and unconjugated hyperbilirubinemia In other words, even two people with the same mildly elevated bilirubin will respond differently to fasting depending on whether their conjugation capacity is compromised.
Dietary patterns can influence how often jaundice episodes occur. Research on nutrition in Gilbert syndrome has found that avoiding excessive calorie restriction and eating certain vegetable families may help prevent flare-ups.20PubMed Central. Nutrition in Gilbert’s Syndrome-A Systematic Review of Clinical Trials According to the PRISMA Statement This is relevant to the many people with Gilbert syndrome who engage in intermittent fasting or very low-calorie diets for weight management. The visible jaundice is cosmetically annoying but not medically harmful; still, it’s useful to understand the trigger.
Gut Bacteria and Bilirubin Elimination
Once conjugated bilirubin reaches the intestine through bile, gut bacteria play a critical role in completing its metabolism. For decades, scientists knew that intestinal microbes converted bilirubin into urobilinogen (which gives stool its brown color and, after partial reabsorption and kidney filtration, gives urine its yellow tint), but the specific bacterial enzyme responsible was unknown until recently. Researchers identified a gut-microbiota-derived enzyme called BilR as the bilirubin reductase that performs this conversion.21PubMed Central. BilR is a gut microbial enzyme that reduces bilirubin to urobilinogen
This discovery has implications beyond academic curiosity. Newborns have relatively sparse gut microbiomes, which partly explains why they’re so prone to bilirubin buildup. Without enough of the right bacteria, bilirubin that reaches the intestine can get deconjugated by other enzymes and reabsorbed back into the bloodstream (a process called enterohepatic circulation), further driving up indirect bilirubin levels. Adults on prolonged broad-spectrum antibiotics can experience something similar, as antibiotic disruption of the gut flora reduces the microbial capacity to metabolize bilirubin. The identification of BilR has opened up new research questions about whether probiotic approaches or other microbiome interventions could eventually help manage bilirubin levels in vulnerable populations.22PubMed. Gut microbiota and bilirubin metabolism: unveiling new pathways in health and disease
Indirect Bilirubin as an Antioxidant
It’s worth noting that bilirubin isn’t purely a waste product the body is trying to get rid of. At normal physiological concentrations, unconjugated bilirubin functions as a potent antioxidant. In studies of human vascular endothelial cells, bilirubin at concentrations matching the free (unbound) levels found in normal serum showed a dose-dependent ability to protect cells against oxidative stress. Small changes in circulating bilirubin concentrations translated into substantially improved intracellular defense.23Scientific Reports. Bilirubin is an Endogenous Antioxidant in Human Vascular Endothelial Cells
This dual nature of bilirubin, protective at low levels and toxic at high levels, helps explain a curious epidemiological pattern: people with mildly elevated bilirubin, such as those with Gilbert syndrome, appear to have lower rates of cardiovascular disease in some population studies. The antioxidant properties at those slightly above-average concentrations may confer a protective effect on blood vessel walls. The flip side is the neurotoxicity described earlier when levels spike beyond the body’s binding capacity. The line between beneficial and harmful depends on the concentration, the age of the person, and how much albumin is available to keep free bilirubin in check.
Telling Indirect and Direct Bilirubin Problems Apart
When a blood test shows elevated total bilirubin, the split between indirect and direct fractions is the first clue to what’s going on. Predominantly indirect elevations suggest overproduction (hemolysis), underconjugation (Gilbert syndrome, Crigler-Najjar syndrome), or increased enterohepatic recirculation. Predominantly direct elevations point toward liver disease, bile duct obstruction, or rarer inherited conditions like Dubin-Johnson or Rotor syndrome, which involve defects in excreting already-conjugated bilirubin.24Russian Journal of Woman and Child Health. Hereditary disorders of bilirubin metabolism: molecular basis and differential diagnosis (literature review)
The distinction matters because the treatment targets are completely different. An indirect bilirubin problem might require addressing hemolysis, managing a genetic condition, or simply reassuring a patient with Gilbert syndrome that nothing needs to be done. A direct bilirubin problem might require imaging the bile ducts, evaluating the liver for inflammation or scarring, or in some cases surgery. Doctors don’t treat “high bilirubin” generically; they treat the underlying cause, and the indirect-versus-direct split is the fork in the diagnostic road.